Tembexa
NDC 64678-010, Brincidofovir, tablet, film coated, from Emergent BioDefense Operations Lansing LLC.
- Product NDC
- 64678-010
- Status
- Listed
- Labeler
- Emergent BioDefense Operations Lansing LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214461
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64678-010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRINCIDOFOVIR100 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64678-010-01 | 64678001001 | 4 TABLET, FILM COATED in 1 BLISTER PACK (64678-010-01) |
| 64678-010-02 | 64678001002 | 4 TABLET, FILM COATED in 1 BLISTER PACK (64678-010-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/209aa94b-c613-4880-ad89-41be83d12c0a
Use it
Look up 64678-010 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64678-010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64678-010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.